EXACT Sciences Corporation (NASDAQ: EXAS) is having an overwhelmingly strong start to the trading session in the pre-market hours this morning, and for good reason. The company announced that it has entered into an agreement with Pfizer Inc. (NYSE: PFE) surrounding its proprietary Cologuard cancer screening test. Of course, the news excited investors, sending the … Read more
Antares Pharma Inc (NASDAQ: ATRS) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that it has entered into a collaboration agreement with Pfizer Inc. (NYSE: PFE) surrounding the development of a combination drug. Today, we’ll talk about: The collaboration; what we’re seeing from ATRS … Read more
Pfizer Inc. (NYSE: PFE) is making mainstream headlines this morning, and for good reason. The company announced that it plans on reorganizing its business, splitting it into three different sebments. Today, we’ll talk about: The reorganization of the company; what we’re seeing from PFE as a result; and what we’ll be watching for ahead. PFE … Read more
Pfizer Inc. (NYSE: PFE) is having an interesting start in the pre-market hours today, and for good reason. The company released its earnings report, which proved to be a mixed bag of data. Of course, since the release, investors have been reacting, sending the value of the stock up early on, and most recently, down. … Read more
Bristol-Myers Squibb Co (NYSE: BMY) is is experiencing a relatively strong spike in the market at the moment, and for good reason. There are rumors surfacing that the company will soon be taken over. Of course, these rumors are leading to excitement among investors, sending the stock upward. Of course, our partners at Trade Ideas … Read more
Pfizer Inc. (NYSE: PFE) was off to what looked like it was going to be a rough day in the market today. In fact, at the opening bell, the stock was trading well in the red. However, minutes ago, news broke of a new drug approval, leading to gains in the value of the stock. … Read more
Pfizer Inc. (NYSE: PFE) Pfizer is having an incredible start to the week this week, and for good reason. The company announced that it has made the decision to acquire Bamboo Therapeutics. Today, we’ll talk about the acquisition, how the stock reacted to the news, and what we can expect to see from PFE moving … Read more
Anacor Pharmaceuticals Inc (NASDAQ: ANAC) | Pfizer Inc. (NYSE: PFE) Anacor Pharmaceuticals is having an absolutely incredible start to the trading day today, and for good reason. Early this morning, the company announced that it would be acquired by Pfizer. Today, we’ll talk about the details of the acquisition, how the market reacted to the … Read more
Pfizer (NYSE:PFE) & Allergan (NASDAQ:AGN) On November 23, 2015 big pharma giant Pfizer announced that it had set a deal to merge with another pharmaceutical company known as Allergan. The deal totals about $160 billion, and ends up being $363 per Allergan Share. The combined company is expected to keep the Pfizer tickers symbol “PFE” … Read more
Pfizer (NYSE: PFE) Allergan Plc (NYSE: AGN)This morning, Pfizer and Allergan announced that they have entered into a definitive merger agreement. Today, we’ll discuss the details of the agreement and what we can expect to see from the combined company moving forward. PFE & AGN Enter Definitive Merger Agreement As mentioned above, PFE and AGN … Read more